Balance Sheet

Current Liabilities	12.1m
Accounts Payable	1.5m
Accrued Liabilities	10.6m
Non-Current Liabilities	46.6m
Other Non-Current Liabilities	46.6m

Currency: USD

	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022
Assets
Cash & Cash Equivalents	68	307	188	74	35	49	22	29	81	38
Cash Equivalents	68	307	188	74	35	49	22	29	81	38
Short-Term Investments	146	25	57	18	23	10	20	6	0	0
Total Receivables	0	0	1	0	0	0	0	0	0	0
Other Current Assets	11	12	8	10	1	1	2	2	2	2
Total Current Assets	225	345	255	102	58	60	45	36	82	40
PP&E Net	4	19	28	23	0	0	4	3	2	1
PP&E Gross	4	19	28	23	0	0	4	3	2	1
Accumulated Depreciation	23	21	21	6	2	2	2	2	3	3
Note Receivable	0	3	2	0	0	0	0	0	0	0
Long-Term Investments	1	1	0	0	0	0	0	0	0	0
Other Long-Term Assets	1	2	4	1	1	0	1	0	0	0
Total Assets	231 N/A	369 +60%	289 -22%	126 -56%	59 -53%	60 +1%	49 -19%	39 -20%	85 +116%	42 -50%
Liabilities
Accounts Payable	6	6	10	2	1	1	2	3	2	4
Accrued Liabilities	9	18	24	21	5	7	8	8	11	9
Short-Term Debt	0	0	0	0	6	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	7	31	36	0	0	0	0	0	0	0
Total Current Liabilities	22	55	70	24	12	8	10	11	13	14
Long-Term Debt	0	0	20	19	0	0	0	0	0	0
Other Liabilities	7	105	101	0	0	0	32	51	50	48
Total Liabilities	29 N/A	160 +443%	190 +19%	43 -77%	12 -73%	8 -33%	41 +429%	62 +51%	63 +1%	61 -3%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0
Retained Earnings	450	467	596	626	668	679	726	766	812	856
Additional Paid In Capital	651	677	694	708	715	731	734	743	833	837
Other Equity	0	0	0	0	0	0	0	0	0	0
Total Equity	201 N/A	210 +4%	99 -53%	83 -16%	48 -42%	53 +10%	8 -85%	23 N/A	22 N/A	19 N/A
Total Liabilities & Equity	231 N/A	369 +60%	289 -22%	126 -56%	59 -53%	60 +1%	49 -19%	39 -20%	85 +116%	42 -50%
Shares Outstanding
Common Shares Outstanding	48	49	49	50	51	57	57	64	89	89

Infinity Pharmaceuticals Inc
NASDAQ:INFI